NCT04322045 Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening Status UNKNOWN Phase NA
NCT04320147 MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer Status UNKNOWN Phase NA
NCT04319146 Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT04317690 Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey Status COMPLETED Phase N/A
NCT04317625 Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL Status UNKNOWN Phase NA
NCT04307056 Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPY Status COMPLETED Phase NA
NCT04305379 Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical Prostatectomy Status TERMINATED Phase NA
NCT04304079 A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery Status WITHDRAWN Phase NA
NCT04302454 Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04301414 Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer Status COMPLETED Phase EARLY_PHASE1
NCT04300855 Clinical Trial of Green Tea Catechins in Men on Active Surveillance Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04300673 Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients Status UNKNOWN Phase PHASE1/PHASE2
NCT04298983 Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer Status TERMINATED Phase PHASE2
NCT04297410 177Lu-PSMA-I&T Prior to Radical Prostatectomy for Locally Advanced Disease Status UNKNOWN Phase NA
NCT04296578 Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone Status WITHDRAWN Phase PHASE1